The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
119061502 11906150 2 F 200202 20160826 20160111 20160902 EXP FR-BRISTOL-MYERS SQUIBB COMPANY-11742418 BRISTOL MYERS SQUIBB 0.01 YR M Y 3.99000 KG 20160902 CN FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
119061502 11906150 1 PS VIDEX DIDANOSINE 1 Transplacental ONGOING THROUGHOUT THE ENTIRE PREGNANCY. U 20156
119061502 11906150 2 SS EPIVIR LAMIVUDINE 1 Transplacental ONGOING THROUGHOUT THE ENTIRE PREGNANCY. U 0
119061502 11906150 3 SS EPIVIR LAMIVUDINE 1 Oral FROM THE FIRST TO SECOND DAY OF LIFE. 0
119061502 11906150 4 SS VIRAMUNE NEVIRAPINE 1 Transplacental UNK U 0
119061502 11906150 5 SS RETROVIR ZIDOVUDINE 1 Transplacental UNK U 0
119061502 11906150 6 SS RETROVIR ZIDOVUDINE 1 Oral AT DAY 4 OF LIFE. U 0
119061502 11906150 7 C CLAMOXYL AMOXICILLINCLAVULANIC ACID 1 Transplacental UNK U 0
119061502 11906150 8 C LOXEN NICARDIPINE HYDROCHLORIDE 1 Transplacental UNK U 0
119061502 11906150 9 C CELESTENE BETAMETHASONE 1 Transplacental UNK U 0
119061502 11906150 10 C COLPOSEPTINE 2 Transplacental UNK U 0
119061502 11906150 11 C GYNO PEVARYL ECONAZOLE NITRATE 1 Transplacental UNK U 0
119061502 11906150 12 C POLYSILANE JOULLIE 2 Unknown UNK U 0
119061502 11906150 13 C RANIPLEX RANITIDINE HYDROCHLORIDE 1 Unknown AT DAY 3 OF LIFE. U 0
119061502 11906150 14 C MOTILIUM DOMPERIDONE 1 Unknown AT DAY 3 OF LIFE. U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
119061502 11906150 1 Product used for unknown indication
119061502 11906150 2 Product used for unknown indication
119061502 11906150 3 Product used for unknown indication
119061502 11906150 4 Product used for unknown indication
119061502 11906150 5 Product used for unknown indication
119061502 11906150 6 Product used for unknown indication
119061502 11906150 7 Product used for unknown indication
119061502 11906150 8 Product used for unknown indication
119061502 11906150 9 Product used for unknown indication
119061502 11906150 10 Product used for unknown indication
119061502 11906150 11 Product used for unknown indication
119061502 11906150 12 Product used for unknown indication
119061502 11906150 13 Product used for unknown indication
119061502 11906150 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
119061502 11906150 OT
119061502 11906150 HO
119061502 11906150 CA

Reactions reported

Event ID CASEID DRUG REC ACT PT
119061502 11906150 Foetal exposure during pregnancy
119061502 11906150 Gastroduodenitis
119061502 11906150 Hepatomegaly
119061502 11906150 Liver function test increased
119061502 11906150 Oesophagitis
119061502 11906150 Rash
119061502 11906150 Ventricular septal defect

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
119061502 11906150 3 20020203 20020204 0